Loading...

Deanna Kroetz, PhD

Title(s)Professor, Bioengineering
SchoolSchool of Pharmacy
Address1550 4th Street, Bldg 19B
San Francisco CA 94158
Phone415-476-1159
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    National Pharmaceutical Council 1984  - 1984National Pharmaceutical Council Internship Mortar Board Honor Society Rho Chi National Pharmacy Ho
    Cum Laude Graduate Ohio State University College of Pharmacy1985  - 1985Ohio State University Presidential Scholar Eli Lilly Company Achievement Award
    National Institute of Health Training1987  - 1990National Institute of Health Training Grant Trainee
    Pharmacology Research Associate Training1991  - 1993Pharmacology Research Associate Training (PRAT) Fellowship
    Ohio State University College of Pharmacy1995  - 1995Josephine S. Failer Alumni Award
    American Association of Pharmaceutical Scientists 1996  - 1996American Association of Pharmaceutical Scientists Young Investigator Award in Pharmacokinetics, Phar
    American Society for Clinical Pharmacology and Therapeutics2002  - 2002Leon I. Goldberg Young Investigator Award
    American Heart Association2002  - 2002Elected Fellow, High Blood Pressure Research Council of the American Heart Association
    American Association of Pharmaceutical Scientists2008  - 2008Elected Fellow, American Association of Pharmaceutical Scientists
    Pharmacology2008  - 2008Named to Faculty of 1000, Pharmacology

    Collapse Overview 
    Collapse Overview
    The Kroetz lab has two major research areas. A major goal is to understand the role of genetic variation in determining drug response and toxicity. Integrated genomic and functional studies are focused on identifying genetic biomarkers of taxane-induced sensory peripheral neuropathy and response to antiretroviral therapies. A second area of research is on the role of cytochrome P450 eicosanoids in acute and chronic renal dysfunction. Animal and cellular studies are used to test whether inhibition of soluble epoxide hydrolase can be targeted for renoprotection.

    Collapse Research 
    Collapse Research Activities and Funding
    2019 Multi-Drug Efflux Systems GRC/GRS
    NIH/NIAID R13AI145258Feb 6, 2019 - May 31, 2019
    Role: Principal Investigator
    Pharmacogenomics of Microtubule Targeting Agents
    NIH/NCI R01CA192156Jul 2, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
    NIH/NIDDK R01DK084147Aug 1, 2010 - Jul 31, 2015
    Role: Principal Investigator
    CYTOCHROME P450 DEPENDENT ARACHIDONIC ACID METABOLISM
    NIH/NHLBI R01HL053994Aug 1, 1996 - Jul 31, 2006
    Role: Principal Investigator
    PHARMACOLOGICAL EFFECTS OF CYTOCHROME P450 4A METABOLISM
    NIH/NHLBI R29HL053994Aug 1, 1996 - Jul 31, 2000
    Role: Principal Investigator
    Pharmaceutical Sciences and Pharmacogenomics
    NIH/NIGMS T32GM007175Jul 1, 1982 - Jun 30, 2022
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Sep 29, 2006
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Featured Videos
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy. Clin Pharmacol Ther. 2020 Jun 20. Chua KC, Xiong C, Ho C, Mushiroda T, Jiang C, Mulkey F, Lai D, Schneider BP, Rashkin SR, Witte JS, Friedman PN, Ratain MJ, McLeod HL, Rugo HS, Shulman LN, Kubo M, Owzar K, Kroetz DL. PMID: 32562552.
      View in: PubMed   Mentions:    Fields:    
    2. P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. Clin Pharmacol Ther. 2020 Apr 10. Stage TB, Mortensen C, Khalaf S, Steffensen V, Hammer HS, Xiong C, Nielsen F, Poetz O, Svenningsen ÅF, Rodriguez-Antona C, Kroetz DL. PMID: 32275773.
      View in: PubMed   Mentions:    Fields:    
    3. Reversible inhibition of efflux transporters by hydrogel microdevices. Eur J Pharm Biopharm. 2019 Dec; 145:76-84. Levy ES, Samy KE, Lamson NG, Whitehead KA, Kroetz DL, Desai TA. PMID: 31639417.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    4. Efficient estimation of grouped survival models. BMC Bioinformatics. 2019 May 28; 20(1):269. Li Z, Lin J, Sibley AB, Truong T, Chua KC, Jiang Y, McCarthy J, Kroetz DL, Allen A, Owzar K. PMID: 31138120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers. Clin Transl Sci. 2019 07; 12(4):388-399. Yee SW, Giacomini MM, Shen H, Humphreys WG, Horng H, Brian W, Lai Y, Kroetz DL, Giacomini KM. PMID: 30982223.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Apical Shear Stress Enhanced Organic Cation Transport in Human OCT2/MATE1-Transfected Madin-Darby Canine Kidney Cells Involves Ciliary Sensing. J Pharmacol Exp Ther. 2019 06; 369(3):523-530. Jayagopal A, Brakeman PR, Soler P, Ferrell N, Fissell W, Kroetz DL, Roy S. PMID: 30910922.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    7. A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service. J Am Coll Clin Pharm. 2019 Jun; 2(3):214-221. Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B. PMID: 32391517.
      View in: PubMed   Mentions:
    8. A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). Clin Pharmacol Ther. 2019 03; 105(3):738-745. Rashkin SR, Chua KC, Ho C, Mulkey F, Jiang C, Mushiroda T, Kubo M, Friedman PN, Rugo HS, McLeod HL, Ratain MJ, Castillos F, Naughton M, Overmoyer B, Toppmeyer D, Witte JS, Owzar K, Kroetz DL. PMID: 30260474.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    9. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle. Clin Pharmacol Ther. 2019 07; 106(1):148-163. Bartelink IH, Jones EF, Shahidi-Latham SK, Lee PRE, Zheng Y, Vicini P, van 't Veer L, Wolf D, Iagaru A, Kroetz DL, Prideaux B, Cilliers C, Thurber GM, Wimana Z, Gebhart G. PMID: 30107040.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 11; 34(11):982-992. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. PMID: 29973058.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    11. Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 10 01; 24(19):4734-4744. Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL. PMID: 29871907.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity. Drug Metab Dispos. 2018 05; 46(5):636-642. Eclov RJ, Kim MJ, Smith R, Ahituv N, Kroetz DL. PMID: 29467213.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci. Pharmacogenet Genomics. 2018 02; 28(2):49-55. Sucheston-Campbell LE, Clay-Gilmour AI, Barlow WE, Budd GT, Stram DO, Haiman CA, Sheng X, Yan L, Zirpoli G, Yao S, Jiang C, Owzar K, Hershman D, Albain KS, Hayes DF, Moore HC, Hobday TJ, Stewart JA, Rizvi A, Isaacs C, Salim M, Gralow JR, Hortobagyi GN, Livingston RB, Kroetz DL, Ambrosone CB. PMID: 29278617.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro. Br J Clin Pharmacol. 2018 03; 84(3):510-519. Stage TB, Graff M, Wong S, Rasmussen LL, Nielsen F, Pottegård A, Brøsen K, Kroetz DL, Khojasteh SC, Damkier P. PMID: 29105855.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review. Clin Pharmacokinet. 2018 01; 57(1):7-19. Stage TB, Bergmann TK, Kroetz DL. PMID: 28612269.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression. Pharmacogenet Genomics. 2017 Dec; 27(12):454-463. Eclov RJ, Kim MJ, Chhibber A, Smith RP, Ahituv N, Kroetz DL. PMID: 28930109.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    17. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther. 2018 02; 182:152-160. Li M, Kroetz DL. PMID: 28882537.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    18. Genetic advances uncover mechanisms of chemotherapy-induced peripheral neuropathy. Clin Pharmacol Ther. 2017 04; 101(4):450-452. Chua KC, Kroetz DL. PMID: 27981569.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    19. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus. Drug Metab Dispos. 2017 02; 45(2):208-215. Eclov RJ, Kim MJ, Smith RP, Liang X, Ahituv N, Kroetz DL. PMID: 27856528.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    20. ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenomics J. 2018 01; 18(1):35-42. Li M, Seiser EL, Baldwin RM, Ramirez J, Ratain MJ, Innocenti F, Kroetz DL. PMID: 27845419.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    21. Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1. Clin Pharmacol Ther. 2016 Nov; 100(5):524-536. Yee SW, Giacomini MM, Hsueh CH, Weitz D, Liang X, Goswami S, Kinchen JM, Coelho A, Zur AA, Mertsch K, Brian W, Kroetz DL, Giacomini KM. PMID: 27447836.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    22. Best Practices for Clinical and Translational Research and Implementation. Clin Transl Sci. 2016 Oct; 9(5):231-232. Kroetz DL. PMID: 27546282.
      View in: PubMed   Mentions: 1     Fields:    
    23. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS. 2016 07 17; 30(11):1807-15. Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, Mclaren PJ, Mushiroda T, Kubo M, Byakwaga H, Hunt PW, Kroetz DL. PMID: 27088321.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. Clin Cancer Res. 2016 Oct 01; 22(19):4890-4900. Hertz DL, Owzar K, Lessans S, Wing C, Jiang C, Kelly WK, Patel J, Halabi S, Furukawa Y, Wheeler HE, Sibley AB, Lassiter C, Weisman L, Watson D, Krens SD, Mulkey F, Renn CL, Small EJ, Febbo PG, Shterev I, Kroetz DL, Friedman PN, Mahoney JF, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Dorsey SG, Dolan ME, Morris MJ, Ratain MJ, McLeod HL. PMID: 27143689.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCTClinical Trials
    25. Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. Pharmacogenomics J. 2017 03; 17(2):137-145. Chhibber A, French CE, Yee SW, Gamazon ER, Theusch E, Qin X, Webb A, Papp AC, Wang A, Simmons CQ, Konkashbaev A, Chaudhry AS, Mitchel K, Stryke D, Ferrin TE, Weiss ST, Kroetz DL, Sadee W, Nickerson DA, Krauss RM, George AL, Schuetz EG, Medina MW, Cox NJ, Scherer SE, Giacomini KM, Brenner SE. PMID: 26856248.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    26. Transforming Translation: Impact of Clinical and Translational Science. Clin Transl Sci. 2016 Feb; 9(1):3-5. Wagner JA, Kroetz DL. PMID: 26678255.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Multidrug resistance-associated protein 4 is a determinant of arsenite resistance. Oncol Rep. 2016 Jan; 35(1):147-54. Yuan B, Yoshino Y, Fukushima H, Markova S, Takagi N, Toyoda H, Kroetz DL. PMID: 26497925.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    28. Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clin Cancer Res. 2015 Oct 01; 21(19):4337-46. Komatsu M, Wheeler HE, Chung S, Low SK, Wing C, Delaney SM, Gorsic LK, Takahashi A, Kubo M, Kroetz DL, Zhang W, Nakamura Y, Dolan ME. PMID: 26015512.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    29. PharmGKB summary: very important pharmacogene information for human leukocyte antigen B. Pharmacogenet Genomics. 2015 Apr; 25(4):205-21. Barbarino JM, Kroetz DL, Klein TE, Altman RB. PMID: 25647431.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiol Dis. 2015 May; 77:127-40. Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL. PMID: 25766675.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    31. Genomic architecture of pharmacological efficacy and adverse events. Pharmacogenomics. 2014 Dec; 15(16):2025-48. Chhibber A, Kroetz DL, Tantisira KG, McGeachie M, Cheng C, Plenge R, Stahl E, Sadee W, Ritchie MD, Pendergrass SA. PMID: 25521360.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. PharmGKB summary: abacavir pathway. Pharmacogenet Genomics. 2014 May; 24(5):276-82. Barbarino JM, Kroetz DL, Altman RB, Klein TE. PMID: 24625462.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. Clin Pharmacol Ther. 2014 May; 95(5):499-500. Martin MA, Hoffman JM, Freimuth RR, Klein TE, Dong BJ, Pirmohamed M, Hicks JK, Wilkinson MR, Haas DW, Kroetz DL. PMID: 24561393.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    34. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J. 2014 Aug; 14(4):336-42. Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DL. PMID: 24513692.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    35. Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention. J Clin Pharmacol. 2014 May; 54(5):574-83. Nicol MR, Fedoriw Y, Mathews M, Prince HM, Patterson KB, Geller E, Mollan K, Mathews S, Kroetz DL, Kashuba AD. PMID: 24343710.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    36. Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers". Clin Pharmacol Ther. 2014 Mar; 95(3):252. Markova SM, Schwartz JB, Kroetz DL. PMID: 24346422.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes? Pharmacogenet Genomics. 2013 Nov; 23(11):591-6. Micheli JE, Chinn LW, Shugarts SB, Patel A, Martin JN, Bangsberg DR, Kroetz DL. PMID: 23982262.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. ABCC4 is regulated by microRNA-124a and microRNA-506. Biochem Pharmacol. 2014 Feb 01; 87(3):515-22. Markova SM, Kroetz DL. PMID: 24184504.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    39. Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway. Mol Pharmacol. 2013 Dec; 84(6):925-34. Liu Y, Lu X, Nguyen S, Olson JL, Webb HK, Kroetz DL. PMID: 24092818.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    40. Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics. 2013 Aug; 23(8):383-94. Motsinger-Reif AA, Jorgenson E, Relling MV, Kroetz DL, Weinshilboum R, Cox NJ, Roden DM. PMID: 20639796.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    41. Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther. 2013 Dec; 94(6):678-86. Markova SM, De Marco T, Bendjilali N, Kobashigawa EA, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie AE, Khojasteh C, McGlothlin D, Wu AH, Hsueh WC, Witte JS, Schwartz JB, Kroetz DL. PMID: 23863877.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    42. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenet Genomics. 2013 Jul; 23(7):355-64. Tamraz B, Fukushima H, Wolfe AR, Kaspera R, Totah RA, Floyd JS, Ma B, Chu C, Marciante KD, Heckbert SR, Psaty BM, Kroetz DL, Kwok PY. PMID: 23652407.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    43. Abacavir pharmacogenetics--from initial reports to standard of care. Pharmacotherapy. 2013 Jul; 33(7):765-75. Martin MA, Kroetz DL. PMID: 23649914.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenet Genomics. 2013 Jan; 23(1):29-33. Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ. PMID: 23188068.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    45. Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15; 19(2):491-9. Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, Owzar K, Jiang C, Watson D, Shterev I, Kubo M, Zembutsu H, Winer EP, Hudis CA, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL, Cox NJ, Dolan ME. PMID: 23204130.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    46. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. J Natl Cancer Inst. 2012 Aug 22; 104(16):1264; author reply 1266-8. Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA. PMID: 22851270.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    47. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012 Sep 15; 18(18):5099-109. Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL. PMID: 22843789.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    48. In vitro metabolism of piperaquine is primarily mediated by CYP3A4. Xenobiotica. 2012 Nov; 42(11):1088-95. Lee TM, Huang L, Johnson MK, Lizak P, Kroetz D, Aweeka F, Parikh S. PMID: 22671777.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    49. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. Pharmacogenomics J. 2013 Oct; 13(5):396-402. Nguyen TD, Markova S, Liu W, Gow JM, Baldwin RM, Habashian M, Relling MV, Ratain MJ, Kroetz DL. PMID: 22664480.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    50. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor ?B signaling. J Pharmacol Exp Ther. 2012 Jun; 341(3):725-34. Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, Olson JL, Kroetz DL. PMID: 22414856.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    51. Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience. Cancer. 2012 Oct 15; 118(20):5060-8. Peppercorn J, Shapira I, Deshields T, Kroetz D, Friedman P, Spears P, Collyar DE, Shulman LN, Dressler L, Bertagnolli MM. PMID: 22415847.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    52. Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Clin Pharmacol Ther. 2012 Apr; 91(4):734-8. Martin MA, Klein TE, Dong BJ, Pirmohamed M, Haas DW, Kroetz DL. PMID: 22378157.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    53. Contribution of aquaporin 9 and multidrug resistance-associated protein 2 to differential sensitivity to arsenite between primary cultured chorion and amnion cells prepared from human fetal membranes. Toxicol Appl Pharmacol. 2011 Dec 01; 257(2):198-208. Yoshino Y, Yuan B, Kaise T, Takeichi M, Tanaka S, Hirano T, Kroetz DL, Toyoda H. PMID: 21945491.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    54. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics. 2011 May; 21(5):280-8. Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM. PMID: 21386754.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    55. Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping. Pharmacogenomics J. 2012 Jun; 12(3):214-26. Matsson P, Yee SW, Markova S, Morrissey K, Jenkins G, Xuan J, Jorgenson E, Kroetz DL, Giacomini KM. PMID: 21383772.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    56. Functional characterization of liver enhancers that regulate drug-associated transporters. Clin Pharmacol Ther. 2011 Apr; 89(4):571-8. Kim MJ, Skewes-Cox P, Fukushima H, Hesselson S, Yee SW, Ramsey LB, Nguyen L, Eshragh JL, Castro RA, Wen CC, Stryke D, Johns SJ, Ferrin TE, Kwok PY, Relling MV, Giacomini KM, Kroetz DL, Ahituv N. PMID: 21368754.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    57. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics. 2011 Mar; 21(3):152-61. Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE, Altman RB. PMID: 20216335.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    58. Exploiting the complexity of the genome and transcriptome using pharmacogenomics towards personalized medicine. Genome Biol. 2011; 12(1):301. Hoppe R, Brauch H, Kroetz DL, Esteller M. PMID: 21241526.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    59. Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains. Protein Sci. 2010 Nov; 19(11):2110-21. Kelly L, Fukushima H, Karchin R, Gow JM, Chinn LW, Pieper U, Segal MR, Kroetz DL, Sali A. PMID: 20799350.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    60. Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics. 2010 Jan; 20(1):45-57. Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB. PMID: 20010382.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    61. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology. Clin Pharmacol Ther. 2010 Jan; 87(1):109-16. Kroetz DL, Yee SW, Giacomini KM. PMID: 19940846.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    62. Institutional Profile: The University of California Pharmacogenomics Center: at the interface of genomics, biological mechanisms and drug therapy. Pharmacogenomics. 2009 Oct; 10(10):1569-76. Kroetz DL, Ahituv N, Burchard EG, Guo S, Sali A, Giacomini KM. PMID: 19842929.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. A survey of integral alpha-helical membrane proteins. J Struct Funct Genomics. 2009 Dec; 10(4):269-80. Kelly L, Pieper U, Eswar N, Hays FA, Li M, Roe-Zurz Z, Kroetz DL, Giacomini KM, Stroud RM, Sali A. PMID: 19760129.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    64. Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. PLoS One. 2009 Sep 09; 4(9):e6942. Hesselson SE, Matsson P, Shima JE, Fukushima H, Yee SW, Kobayashi Y, Gow JM, Ha C, Ma B, Poon A, Johns SJ, Stryke D, Castro RA, Tahara H, Choi JH, Chen L, Picard N, Sjödin E, Roelofs MJ, Ferrin TE, Myers R, Kroetz DL, Kwok PY, Giacomini KM. PMID: 19742321.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    65. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol. 2009 Jun 01; 27(16):2604-14. Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ramírez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ. PMID: 19349540.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    66. Evolutionary conservation of vertebrate blood-brain barrier chemoprotective mechanisms in Drosophila. J Neurosci. 2009 Mar 18; 29(11):3538-50. Mayer F, Mayer N, Chinn L, Pinsonneault RL, Kroetz D, Bainton RJ. PMID: 19295159.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    67. Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults. PLoS One. 2008; 3(12):e3981. Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL. PMID: 19096711.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    68. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J Pharmacol Exp Ther. 2008 Dec; 327(3):707-15. Fife KL, Liu Y, Schmelzer KR, Tsai HJ, Kim IH, Morisseau C, Hammock BD, Kroetz DL. PMID: 18815352.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    69. Nicotine metabolism in pregnant and nonpregnant rabbits. Nicotine Tob Res. 2008 Aug; 10(8):1385-90. Tutka P, Dempsey DA, Jacob P, Benowitz NL, Kroetz DL. PMID: 18686186.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    70. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther. 2008 Jun; 325(3):859-68. Abla N, Chinn LW, Nakamura T, Liu L, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Ferrin TE, Giacomini KM, Kroetz DL. PMID: 18364470.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    71. Substrate-dependent effects of human ABCB1 coding polymorphisms. J Pharmacol Exp Ther. 2008 May; 325(2):435-42. Gow JM, Hodges LM, Chinn LW, Kroetz DL. PMID: 18287207.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    72. The effects of ABCB1 3'-untranslated region variants on mRNA stability. Drug Metab Dispos. 2008 Jan; 36(1):10-5. Gow JM, Chinn LW, Kroetz DL. PMID: 17940136.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    73. Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein. J Antimicrob Chemother. 2007 Jul; 60(1):61-7. Chinn LW, Gow JM, Tse MM, Becker SL, Kroetz DL. PMID: 17510066.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    74. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007 May; 4(2):65-72. Bangsberg DR, Kroetz DL, Deeks SG. PMID: 17547827.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    75. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metab Dispos. 2007 Jul; 35(7):1126-34. Ng VY, Huang Y, Reddy LM, Falck JR, Lin ET, Kroetz DL. PMID: 17431031.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    76. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia. 2007 Apr; 48(4):674-83. Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM. PMID: 17437410.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther. 2007 Aug; 82(2):197-203. Parikh S, Ouedraogo JB, Goldstein JA, Rosenthal PJ, Kroetz DL. PMID: 17361129.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    78. Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. PLoS Genet. 2007 Mar 09; 3(3):e39. Jeong H, Herskowitz I, Kroetz DL, Rine J. PMID: 17352537.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    79. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007 Mar; 81(3):328-45. Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I. PMID: 17339863.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimals
    80. ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther. 2007 Feb; 81(2):265-9. Chinn LW, Kroetz DL. PMID: 17259950.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    81. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Clin Pharmacol Ther. 2007 Jan; 81(1):42-9. de Jong FA, Scott-Horton TJ, Kroetz DL, McLeod HL, Friberg LE, Mathijssen RH, Verweij J, Marsh S, Sparreboom A. PMID: 17185998.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    82. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2462-8. Ng VY, Morisseau C, Falck JR, Hammock BD, Kroetz DL. PMID: 16917105.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    83. Role for drug transporters beyond tumor resistance: hepatic functional imaging and genotyping of multidrug resistance transporters for the prediction of irinotecan toxicity. J Clin Oncol. 2006 Sep 10; 24(26):4225-7. Kroetz DL. PMID: 16895999.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease. J Pharmacol Exp Ther. 2006 Aug; 318(2):835-9. Xu F, Ng VY, Kroetz DL, de Montellano PR. PMID: 16707724.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    85. MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet. 2006 Apr; 21(2):126-32. Komoto C, Nakamura T, Sakaeda T, Kroetz DL, Yamada T, Omatsu H, Koyama T, Okamura N, Miki I, Tamura T, Aoyama N, Kasuga M, Okumura K. PMID: 16702732.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    86. PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters. Pharmacol Rev. 2006 Mar; 58(1):3-4. Shu Y, Urban TJ, Leabman MK, Fujita T, Erdman AR, Lagpacan LL, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Taylor TR, Chan W, De La Cruz M, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Herskowitz I, Kroetz DL, Giacomini KM. PMID: 16507878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    87. PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network. Pharmacol Rev. 2006 Mar; 58(1):1-2. Nguyen TD, Gow JM, Chinn LW, Kelly L, Jeong H, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson E, Taylor T, Ferrin TE, Sali A, Giacomini KM, Kroetz DL. PMID: 16507877.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network. Pharmacol Rev. 2006 Mar; 58(1):5-6. Badagnani I, Sorani M, Edwards RH, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson EJ, Taylor T, Chan W, De La Cruz M, Ferrin TE, Burchard EG, Herskowitz I, Kroetz DL, Giacomini KM. PMID: 16507879.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. Induction of renal cytochrome P450 arachidonic acid epoxygenase activity by dietary gamma-linolenic acid. J Pharmacol Exp Ther. 2006 May; 317(2):732-8. Yu Z, Ng VY, Su P, Engler MM, Engler MB, Huang Y, Lin E, Kroetz DL. PMID: 16421287.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    90. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther. 2005 Dec; 78(6):559-81. Andersson T, Flockhart DA, Goldstein DB, Huang SM, Kroetz DL, Milos PM, Ratain MJ, Thummel K. PMID: 16338273.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    91. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005 Oct; 15(10):693-704. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. PMID: 16141795.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansAnimalsCells
    92. Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2005 Sep; 289(3):F552-61. Seubert JM, Xu F, Graves JP, Collins JB, Sieber SO, Paules RS, Kroetz DL, Zeldin DC. PMID: 15798089.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    93. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation. Annu Rev Pharmacol Toxicol. 2005; 45:413-38. Kroetz DL, Xu F. PMID: 15822183.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimals
    94. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm Res. 2004 Jun; 21(6):904-13. Pauli-Magnus C, Kroetz DL. PMID: 15212152.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    95. Vascular localization of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol. 2004 Apr; 286(4):F720-6. Yu Z, Davis BB, Morisseau C, Hammock BD, Olson JL, Kroetz DL, Weiss RH. PMID: 14665429.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    96. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. J Pharmacol Exp Ther. 2004 Mar; 308(3):887-95. Xu F, Falck JR, Ortiz de Montellano PR, Kroetz DL. PMID: 14634044.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    97. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects. Clin Pharmacol Ther. 2003 Nov; 74(5):487-98. Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL. PMID: 14586389.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    98. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics. 2003 Aug; 13(8):481-94. Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG. PMID: 12893986.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    99. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A. 2003 May 13; 100(10):5896-901. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, Kroetz DL, Ferrin TE, Clark AG, Risch N, Herskowitz I, Giacomini KM. PMID: 12719533.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    100. Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega-hydroxylase activity. Am J Physiol Regul Integr Comp Physiol. 2002 Sep; 283(3):R710-20. Xu F, Straub WO, Pak W, Su P, Maier KG, Yu M, Roman RJ, Ortiz De Montellano PR, Kroetz DL. PMID: 12185006.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    101. MDR1 reference sequence and reference function. Clin Pharmacol Ther. 2002 Jul; 72(1):100-1. Pauli-Magnus C, Kroetz DL. PMID: 12152008.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    102. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol. 2002 Jun; 13(3):273-83. Kroetz DL, Zeldin DC. PMID: 12045397.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    103. Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 family. Biochemistry. 2002 May 07; 41(18):5931-7. LeBrun LA, Xu F, Kroetz DL, Ortiz de Montellano PR. PMID: 11980497.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    104. Candidate gene approach for pharmacogenetic studies. Pharmacogenomics. 2002 Jan; 3(1):47-56. Ring HZ, Kroetz DL. PMID: 11966402.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000 Nov 24; 87(11):992-8. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL. PMID: 11090543.
      View in: PubMed   Mentions: 162     Fields:    Translation:AnimalsCells
    106. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Mol Pharmacol. 2000 May; 57(5):1011-20. Yu Z, Huse LM, Adler P, Graham L, Ma J, Zeldin DC, Kroetz DL. PMID: 10779386.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    107. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system. Drug Metab Dispos. 2000 Mar; 28(3):329-34. Zhang L, Gorset W, Washington CB, Blaschke TF, Kroetz DL, Giacomini KM. PMID: 10681378.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    108. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid. Pharm Res. 2000 Feb; 17(2):216-21. Spiegelstein O, Kroetz DL, Levy RH, Yagen B, Hurst SI, Levi M, Haj-Yehia A, Bialer M. PMID: 10751038.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    109. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch Biochem Biophys. 2000 Jan 01; 373(1):63-71. Hoch U, Zhang Z, Kroetz DL, Ortiz de Montellano PR. PMID: 10620324.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    110. The effects of a diet rich in docosahexaenoic acid on organ and vascular fatty acid composition in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1999 Nov; 61(5):289-95. Engler MM, Engler MB, Kroetz DL, Boswell KD, Neeley E, Krassner SM. PMID: 10670690.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    111. Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc Exp Biol Med. 1999 May; 221(1):32-8. Engler MM, Engler MB, Goodfriend TL, Ball DL, Yu Z, Su P, Kroetz DL. PMID: 10320629.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    112. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem. 1998 Nov 20; 273(47):31581-9. Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. PMID: 9813074.
      View in: PubMed   Mentions: 48     Fields:    Translation:AnimalsCells
    113. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe. Biochemistry. 1998 Sep 08; 37(36):12536-45. Wang H, Dick R, Yin H, Licad-Coles E, Kroetz DL, Szklarz G, Harlow G, Halpert JR, Correia MA. PMID: 9730826.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    114. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol. 1998 08; 275(2):R426-38. Su P, Kaushal KM, Kroetz DL. PMID: 9688677.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    115. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol. 1997 Sep; 52(3):362-72. Kroetz DL, Huse LM, Thuresson A, Grillo MP. PMID: 9281597.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    116. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995 Jun; 15(6):3012-22. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. PMID: 7539101.
      View in: PubMed   Mentions: 329     Fields:    Translation:AnimalsCells
    117. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol. 1994 Jun 01; 47(11):1969-79. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, Levy RH. PMID: 8010982.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    118. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry. 1993 Nov 02; 32(43):11606-17. Kroetz DL, McBride OW, Gonzalez FJ. PMID: 8218228.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    119. In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide. Clin Pharmacol Ther. 1993 Nov; 54(5):485-97. Kroetz DL, Loiseau P, Guyot M, Levy RH. PMID: 8222491.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    120. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation. Epilepsia. 1993 Sep-Oct; 34(5):954-9. Pisani F, Haj-Yehia A, Fazio A, Artesi C, Oteri G, Perucca E, Kroetz DL, Levy RH, Bialer M. PMID: 8104783.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    121. Measurement of in vivo microsomal epoxide hydrolase activity in white subjects. Clin Pharmacol Ther. 1993 Mar; 53(3):306-15. Kroetz DL, Kerr BM, McFarland LV, Loiseau P, Wilensky AJ, Levy RH. PMID: 8453849.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells